Pasar al contenido principal

EPIGENETICA DEL PROCESO DE TRANSICION DE EPITELIO A MESENQUIMA Y SU REVERSION

BFU2017-85420-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

TBL1 is required for the mesenchymal phenotype of transformed breast cancer cells

  • Rivero, Sabrina
  • Gómez-Marín, Elena
  • Guerrero-Martínez, José A.
  • García-Martínez, Jorge
  • Reyes, José C.
The epithelial-to-mesenchymal transition (EMT) and its reversion (MET) are related to tumor cell dissemination and migration, tumor circulating cell generation, cancer stem cells, chemoresistance, and metastasis formation. To identify chromatin and epigenetic factors possibly involved in the process of EMT, we compare the levels of expression of epigenetic genes in a transformed human breast epithelial cell line (HMEC-RAS) versus a stable clone of the same cell line expressing the EMT master regulator ZEB1 (HMEC-RAS-ZEB1). One of the factors strongly induced in the HMEC-RAS-ZEB1 cells was Transducin beta-like 1 (TBL1), a component of the NCoR complex, which has both corepressor and coactivator activities. We show that TBL1 interacts with ZEB1 and that both factors cooperate to repress the promoter of the epithelial gene E-cadherin (CDH1) and to autoactivate the ZEB1 promoter. Consistent with its central role, TBL1 is required for mesenchymal phenotypes of transformed breast epithelial and breast cancer cell lines of the claudin-low subtype. Importantly, a high expression of the TBL1 gene correlates with poor prognosis and increased proportion of metastasis in breast cancer patients, indicating that the level of TBL1 expression can be used as a prognostic marker., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P and BFU2017-85420-R to J.C.R.), the Junta de Andalucía (BIO-321), and the European Union (FEDER). CABIMER is a Center partially funded by the Junta de Andalucía.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Overexpression of canonical prefoldin associates with the risk of mortality and metastasis in non-small cell lung cancer

  • Peñate, Xenia
  • Praena-Fernández, Juan Manuel
  • Romero Pareja, Pedro
  • Enguix-Riego, María del Valle
  • Payán-Bravo, Laura
  • Vieites, Begoña
  • Gómez Izquierdo, Lourdes
  • Jaen Olasolo, Javier
  • Rivin del Campo, Eleonor
  • Reyes, José C.
  • Chávez, Sebastián
  • López-Guerra, José Luis
Canonical prefoldin is a protein cochaperone composed of six different subunits (PFDN1 to 6). PFDN1 overexpression promotes epithelial–mesenchymal transition (EMT) and increases the growth of xenograft lung cancer (LC) cell lines. We investigated whether this putative involvement of canonical PFDN in LC translates into the clinic. First, the mRNA expression of 518 non-small cell LC (NSCLC) cases from The Cancer Genome Atlas (TCGA) database was evaluated. Patients with PFDN1 overexpression had lower overall survival (OS; 45 vs. 86 months; p = 0.034). We then assessed the impact of PFDN expression on outcome in 58 NSCLC patients with available tumor tissue samples. PFDN1, 3, and 5 overexpression were found in 38% (n = 22), 53% (n = 31), and 41% (n = 24) of tumor samples. PFDN1, 3, and 5 overexpression were significantly associated with lower OS, lower disease-free survival (DFS), and lower distant metastasis-free survival (DMFS) for PFDN1 and 3 with a trend for PFDN5. In multivariate analysis, PFDN5 retained significance for OS (hazard ratio (HR) 2.56; p = 0.007) and PFDN1 for DFS (HR 2.53; p = 0.010) and marginally for DMFS (HR 2.32; p = 0.053). Our results indicate that protein response markers, such as PFDN1, 3, and 5, may complement mRNA signatures and be useful for determining the most appropriate therapy for NSCLC patients., This work was co-funded by the Spanish Ministry of Economy and Competitiveness (BFU2017-85420-R to JCR and BFU2016-7772-C3-1-P to SC) and by the Andalusian Government (BIO-271) and the University of Seville (US-1256285 to SC) in cooperation with the European Regional Development Fund., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

TGFβ promotes widespread enhancer chromatin opening and operates on genomic regulatory domains

  • Guerrero-Martínez, José A.
  • Ceballos-Chávez, María
  • Koehler, Florian
  • Peiró, Sandra
  • Reyes, José C.
The Transforming Growth Factor-β (TGFβ) signaling pathway controls transcription by regulating enhancer activity. How TGFβ-regulated enhancers are selected and what chromatin changes are associated with TGFβ-dependent enhancers regulation are still unclear. Here we report that TGFβ treatment triggers fast and widespread increase in chromatin accessibility in about 80% of the enhancers of normal mouse mammary epithelial-gland cells, irrespective of whether they are activated, repressed or not regulated by TGFβ. This enhancer opening depends on both the canonical and non-canonical TGFβ pathways. Most TGFβ-regulated genes are located around enhancers regulated in the same way, often creating domains of several co-regulated genes that we term TGFβ regulatory domains (TRD). CRISPR-mediated inactivation of enhancers within TRDs impairs TGFβ-dependent regulation of all co-regulated genes, demonstrating that enhancer targeting is more promiscuous than previously anticipated. The area of TRD influence is restricted by topologically associating domains (TADs) borders, causing a bias towards co-regulation within TADs., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P and BFU2017-85420-R to J.C. Reyes), the Junta de Andalucía (BIO-321), “Fundación Vencer El Cancer” (VEC) and the European Union (FEDER). CABIMER is a Center partially funded by the Junta de Andalucía. S.P was supported by the FERO Foundation, La Caixa Foundation (LCF/PR/PR12/51070001) and Cellex Foundation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Human prefoldin modulates co-transcriptional pre-mRNA splicing

  • Payán-Bravo, Laura
  • Fontalva, Sara
  • Peñate, Xenia
  • Cases, Ildefonso
  • Guerrero-Martínez, José A.
  • Pareja-Sánchez, Yerma
  • Odriozola-Gil, Yosu
  • Lara, Ester
  • Jimeno-González, Silvia
  • Suñé, Carlos
  • Muñoz-Centeno, Mari Cruz
  • Reyes, José C.
  • Chávez, Sebastián
Prefoldin is a heterohexameric complex conserved from archaea to humans that plays a cochaperone role during the co-translational folding of actin and tubulin monomers. Additional functions of prefoldin have been described, including a positive contribution to transcription elongation and chromatin dynamics in yeast. Here we show that prefoldin perturbations provoked transcriptional alterations across the human genome. Severe pre-mRNA splicing defects were also detected, particularly after serum stimulation. We found impairment of co-transcriptional splicing during transcription elongation, which explains why the induction of long genes with a high number of introns was affected the most. We detected genome-wide prefoldin binding to transcribed genes and found that it correlated with the negative impact of prefoldin depletion on gene expression. Lack of prefoldin caused global decrease in Ser2 and Ser5 phosphorylation of the RNA polymerase II carboxy-terminal domain. It also reduced the recruitment of the CTD kinase CDK9 to transcribed genes, and the association of splicing factors PRP19 and U2AF65 to chromatin, which is known to depend on CTD phosphorylation. Altogether the reported results indicate that human prefoldin is able to act locally on the genome to modulate gene expression by influencing phosphorylation of elongating RNA polymerase II, and thereby regulating co-transcriptional splicing., Ministerio de Ciencia e Innovación-Agencia Estatal de Investigación [BFU2016-77728-C3-1-P to S.C. and BFU2017-85420-R to J.C.R.] co-financed with European Union funds (FEDER); Andalusian Government [P12-BIO1938MO, BIO271, US-1256285 to S.C., BIO321 to J.C.R.]; Junta de Andalucía (to L.P.-B.). Funding for open access charge: Ministerio de Ciencia e Innovación-Agencia Estatal de Investigación [BFU2016-77728-C3-1-P]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Co-transcriptional splicing efficiency is a gene-specific feature that can be regulated by TGFβ

  • Sánchez-Escabias, Elena
  • Guerrero-Martínez, José A.
  • Reyes, José C.
Differential splicing efficiency of specific introns is a mechanism that dramatically increases protein diversity, based on selection of alternative exons for the final mature mRNA. However, it is unclear whether splicing efficiency of introns within the same gene is coordinated and eventually regulated as a mechanism to control mature mRNA levels. Based on nascent chromatin-associated RNA-sequencing data, we now find that co-transcriptional splicing (CTS) efficiency tends to be similar between the different introns of a gene. We establish that two well-differentiated strategies for CTS efficiency exist, at the extremes of a gradient: short genes that produce high levels of pre-mRNA undergo inefficient splicing, while long genes with relatively low levels of pre-mRNA have an efficient splicing. Notably, we observe that genes with efficient CTS display a higher level of mature mRNA relative to their pre-mRNA levels. Further, we show that the TGFβ signal transduction pathway regulates the general CTS efficiency, causing changes in mature mRNA levels. Taken together, our data indicate that CTS efficiency is a gene-specific characteristic that can be regulated to control gene expression., This work was funded by the Spanish Ministry of Economy and Competitiveness MCIN/AEI/10.13039/501100011033/ (grant numbers BFU2017-85420-R and PID2020-118516GB-I00), the Junta de Andalucía (grant P18-FR-1962 and BIO-321), “Fundación Vencer El Cancer” (VEC) and the European Union FEDER “A way to build Europe”. CABIMER is a Center partially funded by the Junta de Andalucía.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Human prefoldin modulates co-transcriptional pre-mRNA splicing.

  • Payán-Bravo, Laura
  • Fontalva, Sara
  • Peñate, Xenia
  • Cases, Ildefonso
  • Guerrero-Martínez, José A.
  • Pareja-Sánchez, Yerma
  • Odriozola-Gil, Yosu
  • Lara, Ester
  • Jimeno-González, Silvia
  • Suñé, Carlos
  • Muñoz-Centeno, Mari Cruz
  • Reyes, José C.
  • Chávez, Sebastián
Prefoldin is a heterohexameric complex conserved from archaea to humans that plays a cochaperone role during the co-translational folding of actin and tubulin monomers. Additional functions of prefoldin have been described, including a positive contribution to transcription elongation and chromatin dynamics in yeast. Here we show that prefoldin perturbations provoked transcriptional alterations across the human genome. Severe pre-mRNA splicing defects were also detected, particularly after serum stimulation. We found impairment of co-transcriptional splicing during transcription elongation, which explains why the induction of long genes with a high number of introns was affected the most. We detected genome-wide prefoldin binding to transcribed genes and found that it correlated with the negative impact of prefoldin depletion on gene expression. Lack of prefoldin caused global decrease in Ser2 and Ser5 phosphorylation of the RNA polymerase II carboxy-terminal domain. It also reduced the recruitment of the CTD kinase CDK9 to transcribed genes, and the association of splicing factors PRP19 and U2AF65 to chromatin, which is known to depend on CTD phosphorylation. Altogether the reported results indicate that human prefoldin is able to act locally on the genome to modulate gene expression by influencing phosphorylation of elongating RNA polymerase II, and thereby regulating co-transcriptional splicing., Ministerio de Ciencia e Innovación-Agencia Estatal de Investigación [BFU2016-77728-C3-1-P to S.C. and BFU2017-85420-R to J.C.R.] co-financed with European Union funds (FEDER); Andalusian Government [P12-BIO1938MO, BIO271, US-1256285 to S.C., BIO321 to J.C.R.]; Junta de Andalucía (to L.P.-B.). Funding for open access charge: Ministerio de Ciencia e Innovación-Agencia Estatal de Investigación [BFU2016-77728-C3-1-P].
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

TGFβ promotes widespread enhancer chromatin opening and operates on genomic regulatory domains

  • Guerrero-Martínez, Jose A.
  • Ceballos-Chávez, María
  • Koehler, Florian
  • Peiro Sales, Sandra
  • Reyes, Jose C.
Cromatina; Informàtica del genoma; Transcripció, Cromatina; Informática del genoma; Transcripción, Chromatin; Genome informatics; Transcription, The Transforming Growth Factor-β (TGFβ) signaling pathway controls transcription by regulating enhancer activity. How TGFβ-regulated enhancers are selected and what chromatin changes are associated with TGFβ-dependent enhancers regulation are still unclear. Here we report that TGFβ treatment triggers fast and widespread increase in chromatin accessibility in about 80% of the enhancers of normal mouse mammary epithelial-gland cells, irrespective of whether they are activated, repressed or not regulated by TGFβ. This enhancer opening depends on both the canonical and non-canonical TGFβ pathways. Most TGFβ-regulated genes are located around enhancers regulated in the same way, often creating domains of several co-regulated genes that we term TGFβ regulatory domains (TRD). CRISPR-mediated inactivation of enhancers within TRDs impairs TGFβ-dependent regulation of all co-regulated genes, demonstrating that enhancer targeting is more promiscuous than previously anticipated. The area of TRD influence is restricted by topologically associating domains (TADs) borders, causing a bias towards co-regulation within TADs., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P and BFU2017-85420-R to J.C. Reyes), the Junta de Andalucía (BIO-321), “Fundación Vencer El Cancer” (VEC) and the European Union (FEDER). CABIMER is a Center partially funded by the Junta de Andalucía. S.P was supported by the FERO Foundation, La Caixa Foundation (LCF/PR/PR12/51070001) and Cellex Foundation.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

TGFβ promotes widespread enhancer chromatin opening and operates on genomic regulatory domains

  • Guerrero-Martínez, Jose A.
  • Ceballos-Chávez, María
  • Koehler, Florian
  • Peiro Sales, Sandra
  • Reyes, Jose C.
Cromatina; Informàtica del genoma; Transcripció, Cromatina; Informática del genoma; Transcripción, Chromatin; Genome informatics; Transcription, The Transforming Growth Factor-β (TGFβ) signaling pathway controls transcription by regulating enhancer activity. How TGFβ-regulated enhancers are selected and what chromatin changes are associated with TGFβ-dependent enhancers regulation are still unclear. Here we report that TGFβ treatment triggers fast and widespread increase in chromatin accessibility in about 80% of the enhancers of normal mouse mammary epithelial-gland cells, irrespective of whether they are activated, repressed or not regulated by TGFβ. This enhancer opening depends on both the canonical and non-canonical TGFβ pathways. Most TGFβ-regulated genes are located around enhancers regulated in the same way, often creating domains of several co-regulated genes that we term TGFβ regulatory domains (TRD). CRISPR-mediated inactivation of enhancers within TRDs impairs TGFβ-dependent regulation of all co-regulated genes, demonstrating that enhancer targeting is more promiscuous than previously anticipated. The area of TRD influence is restricted by topologically associating domains (TADs) borders, causing a bias towards co-regulation within TADs., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P and BFU2017-85420-R to J.C. Reyes), the Junta de Andalucía (BIO-321), “Fundación Vencer El Cancer” (VEC) and the European Union (FEDER). CABIMER is a Center partially funded by the Junta de Andalucía. S.P was supported by the FERO Foundation, La Caixa Foundation (LCF/PR/PR12/51070001) and Cellex Foundation.